[Immunohistological studies of the skin at the injection site of cases receiving the streptococcal agent OK-432].
D000368:Aged; D001688:Biological Products / Q000008:administration & dosage*; D003110:Colonic Neoplasms / Q000276:immunology / Q000473:pathology*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008262:Macrophage Activation; D008297:Male; D008875:Middle Aged; D010844:Picibanil / Q000008:administration & dosage*; D012867:Skin / Q000276:immunology / Q000473:pathology*; D013274:Stomach Neoplasms / Q000276:immunology / Q000473:pathology*; D013601:T-Lymphocytes / Q000276:immunology
D001688:Biological Products; D010844:Picibanil